Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abubakr Mahmoud

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
BMC Primary Care|April 11, 2025
Impact of hypertension knowledge on adherence to antihypertensive therapy: a cross-sectional study in primary health care centers during the 2024 Sudan conflictMaha Rhamttallah, Abubakr Mahmoud, Eltoum Mohamedelnour, et al.
Annals of Medicine and Surgery (2012)|November 3, 2025
<i>Naegleria fowleri</i> in saline waters: emerging threat of primary amebic meningoencephalitis in KarachiNikil Kumar, Sinnha Kumari, Sadia Sultana, et al.
Annals of Medicine and Surgery (2012)|November 3, 2025
Breaking barriers in HIV management: the rise of long-acting lenacapavirDevya Khaim Chandani, Sahira Khan, Harshika Khaim Chandani, et al.
Annals of Medicine and Surgery (2012)|December 11, 2025
From dietary restriction to disease-targeted therapy: Sephience TM (sepiapterin) in phenylketonuriaHarshika Khaim Chandani, Sahira, Syeda Fadak Zahra Hujjat, et al.
Clinical Case Reports|April 10, 2026
Unmasking Juvenile Systemic Lupus Erythematosus (JSLE): Multisystemic Manifestations in an Adolescent Male, A Rare Case ReportShafaq Nazia, Aliza Andaleeb, Abdul Moiz, et al.
Annals of Medicine and Surgery (2012)|January 7, 2026
Jascayd (nerandomilast): a novel PDE4B inhibitor for idiopathic pulmonary fibrosisSyeda Fadak Zahra Hujjat, Harshika Khaim Chandani, Devya Khaim Chandani, et al.
Annals of Medicine and Surgery (2012)|December 11, 2025
Harliku (nitisinone): first FDA-approved disease-modifying therapy for alkaptonuriaHarshika Khaim Chandani, Syeda Fadak Zahra Hujjat, Devya Khaim Chandani, et al.
Annals of Medicine and Surgery (2012)|June 8, 2026
Enflonsia (clesrovimab) and the future of RSV lower respiratory tract disease prevention in neonatesHarshika K Chandani, Syeda F Zahra Hujjat, Devya K Chandani, et al.
Annals of Medicine and Surgery (2012)|December 11, 2025
Bruton's tyrosine kinase inhibition in ITP: Wayrilz (rilzabrutinib) as a disease-modifying strategySyeda Fadak Zahra Hujjat, Harshika Khaim Chandani, Muhammad Saad Khan, et al.
Annals of Medicine and Surgery (2012)|July 11, 2026
Acute quadriparesis revealing Gitelman syndrome: a case reportHarshika Khaim Chandani, Aasiya Ather, Erum Siddiqui, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
BMC Primary Care|April 11, 2025
Impact of hypertension knowledge on adherence to antihypertensive therapy: a cross-sectional study in primary health care centers during the 2024 Sudan conflictMaha Rhamttallah, Abubakr Mahmoud, Eltoum Mohamedelnour, et al.
Annals of Medicine and Surgery (2012)|November 3, 2025
<i>Naegleria fowleri</i> in saline waters: emerging threat of primary amebic meningoencephalitis in KarachiNikil Kumar, Sinnha Kumari, Sadia Sultana, et al.
Annals of Medicine and Surgery (2012)|November 3, 2025
Breaking barriers in HIV management: the rise of long-acting lenacapavirDevya Khaim Chandani, Sahira Khan, Harshika Khaim Chandani, et al.
Annals of Medicine and Surgery (2012)|December 11, 2025
From dietary restriction to disease-targeted therapy: Sephience TM (sepiapterin) in phenylketonuriaHarshika Khaim Chandani, Sahira, Syeda Fadak Zahra Hujjat, et al.
Clinical Case Reports|April 10, 2026
Unmasking Juvenile Systemic Lupus Erythematosus (JSLE): Multisystemic Manifestations in an Adolescent Male, A Rare Case ReportShafaq Nazia, Aliza Andaleeb, Abdul Moiz, et al.
Annals of Medicine and Surgery (2012)|January 7, 2026
Jascayd (nerandomilast): a novel PDE4B inhibitor for idiopathic pulmonary fibrosisSyeda Fadak Zahra Hujjat, Harshika Khaim Chandani, Devya Khaim Chandani, et al.
Annals of Medicine and Surgery (2012)|December 11, 2025
Harliku (nitisinone): first FDA-approved disease-modifying therapy for alkaptonuriaHarshika Khaim Chandani, Syeda Fadak Zahra Hujjat, Devya Khaim Chandani, et al.
Annals of Medicine and Surgery (2012)|June 8, 2026
Enflonsia (clesrovimab) and the future of RSV lower respiratory tract disease prevention in neonatesHarshika K Chandani, Syeda F Zahra Hujjat, Devya K Chandani, et al.
Annals of Medicine and Surgery (2012)|December 11, 2025
Bruton's tyrosine kinase inhibition in ITP: Wayrilz (rilzabrutinib) as a disease-modifying strategySyeda Fadak Zahra Hujjat, Harshika Khaim Chandani, Muhammad Saad Khan, et al.
Annals of Medicine and Surgery (2012)|July 11, 2026
Acute quadriparesis revealing Gitelman syndrome: a case reportHarshika Khaim Chandani, Aasiya Ather, Erum Siddiqui, et al.
Pageof 2